source
- Ambrose Healthcare acquires AM-Pharma for up to €161 millionAmbrose Healthcare, a British rare‑disease specialist, announced it has completed the acquisition of Dutch biotech AM‑Pharma. The deal values the company at up to 161 million euros (about $181 mill…
- City Therapeutics completes $200 million IPO, earmarks funds for RNAi therapiesCity Therapeutics, based in Cambridge, Massachusetts, launched an IPO raising $200 million, exceeding its original target of 9.7 million shares at $17-$19 per share. The company sold 11.1 million…